Anzeige
Mehr »
Login
Donnerstag, 19.09.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Gold's geheime Rallye: Dieses Minenunternehmen wird 2025 durchstarten.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
621 Leser
Artikel bewerten:
(2)

Smile CDR Inc. : Smile Digital Health Launches CDA Exchange+ to Unify Patient Data for Better Accessibility and Sharing

Smile offers enhanced interoperability with their new solution that converts clinical documents to the widely used FHIR standard.

TORONTO, ON / ACCESSWIRE / May 28, 2024 / Smile Digital Health (Smile), a leading Fast Healthcare Interoperability Resources (FHIR®) health data platform and exchange solutions provider, announced the launch of CDA Exchange+ with their quarterly release on May 23, 2024.

Created for healthcare organizations aiming to upgrade their data interoperability capabilities, CDA Exchange+ is designed to handle the transformation of CDA documents (Clinical Document Architecture) from their existing state to the modern FHIR format-the current standard in healthcare data interoperability.

Based on customer feedback, Smile saw the need to create a robust native CDA ingestion solution with the ability to transform varying CDA document types. CDA Exchange+ is a premium module made to unlock actionable clinical insights, focusing on maximizing the efficiency and reliability of the CDA to FHIR conversion process. The product includes a plug-and-play implementation guide layer for customers to easily select what implementation guide to use for their C-CDA (Consolidated Clinical Document Architecture) to FHIR transformation.

"At Smile, we see the opportunity for data to transform the healthcare industry. To get there, providers, payers and HIEs (Health Information Exchanges) need to be able to leverage their data in new ways. That's where Smile really delivers value. By providing solutions that unify, enrich and elevate data, as well as ensure standards compliance, we help move the industry forward, toward better global health overall," said Duncan Weatherston, Chief Executive Officer, Smile Digital Health. "CDA Exchange+ is part of that first data step, unifying. It allows for the data accessibility and sharing that care teams need to actively achieve their respective goals-to provide the best possible care across the full patient journey."

In addition to enhanced interoperability and better patient care, customers can expect improved data management, through the efficient organization and accuracy of healthcare data and a reduction in costs associated with maintaining multiple data formats. Plus, unlike other products, CDA Exchange+ unlocks Social Determinants of Health data elements via US Core 5.0.1 and USCDIv2, which actively enables population care management.

"When developing new products, we listen to our customers and their challenges. CDA Exchange+ is our offering for customers who want to unlock the value of clinical data by ensuring that data is complete and accurate, and in the easiest format to perform analysis and computations on," said Sam Huiskamp, Senior Product Manager, Data Processing and Optimization, Smile Digital Health. "With CDA Exchange+, customers can transform their diverse C-CDA documents into actionable FHIR resources. Once transformed, customers can enrich and elevate their data with our Master Data Management and Clinical Quality Improvement premium solutions."

To learn more about CDA exchange+, visit Smile's website or contact sales@smiledigitalhealth.com

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data platform fuels healthcare's digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository, our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share health information. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through the intelligent use of information, and ultimately delivering better patient outcomes. For more information, visit SmileDigitalHealth.com.

Contact Information

Victoria Valladolid
Director of Marketing, Smile Digital Health
pr@smiledigitalhealth.com
(877) 537-3343 x 728

SOURCE: Smile Digital Health

.

View the original press release on newswire.com.

© 2024 ACCESSWIRE
Drei potenzielle Vervielfacher aus Osteuropa

In unserem kostenlosen Spezialreport nehmen wir Sie mit auf eine Reise durch die dynamischen und oft unterbewerteten Aktienmärkte Osteuropas. Die Region erlebt ein beeindruckendes Wirtschaftswachstum, das weit über den Erwartungen vieler Analysten liegt. Während westliche Märkte gesättigt erscheinen, bieten osteuropäische Unternehmen einzigartige Investitionsmöglichkeiten zu attraktiven Bewertungen.

Profitieren Sie vom Wachstum Osteuropas!

In dieser Ausgabe stellen wir Ihnen drei Top-Aktien vor, die nicht nur durch solide Fundamentaldaten glänzen, sondern auch durch ein enormes Wachstumspotenzial in den kommenden Jahren. Erfahren Sie, warum diese Favoriten bereit sind, die Märkte zu erobern und wie Sie als Investor von dieser Entwicklung profitieren können.

Verpassen Sie nicht die Chance, Teil dieser aufstrebenden Wirtschaft zu sein. Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, bei welchen unentdeckten Perlen noch enormes Potenzial schlummert.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.